Cargando…
Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials
Co-morbid insomnia and sleep apnea (COMISA) is a highly prevalent and debilitating disorder, which results in additive impairments to patients’ sleep, daytime functioning, and quality of life, and complex diagnostic and treatment decisions for clinicians. Although the presence of COMISA was first re...
Autores principales: | Sweetman, Alexander, Lack, Leon, Bastien, Célyne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956217/ https://www.ncbi.nlm.nih.gov/pubmed/31842520 http://dx.doi.org/10.3390/brainsci9120371 |
Ejemplares similares
-
The State of Art on Co-Morbid Insomnia and Sleep Apnea (COMISA)
por: De Gennaro, Luigi
Publicado: (2021) -
P120 Incidence, persistence and remission of co-morbid insomnia and sleep apnea (COMISA) over time in the Wisconsin Sleep Cohort data
por: Sweetman, A, et al.
Publicado: (2022) -
P086 The insomnia severity index is related to the respiratory arousal threshold in people with Co-Morbid Insomnia and Sleep Apnoea (COMISA)
por: Zheng, J, et al.
Publicado: (2022) -
P139 Co-morbid insomnia and sleep apnoea (COMISA): Identifying patients that are responsive to continuous positive airway pressure therapy
por: Sweetman, A, et al.
Publicado: (2021) -
10-Year Risk for Cardiovascular Disease Associated with COMISA (Co-Morbid Insomnia and Sleep Apnea) in Hypertensive Subjects
por: Draelants, Laura, et al.
Publicado: (2023)